SI1173439T1 - Haloalkoxy imidazonaphthyridines - Google Patents

Haloalkoxy imidazonaphthyridines

Info

Publication number
SI1173439T1
SI1173439T1 SI200030157T SI200030157T SI1173439T1 SI 1173439 T1 SI1173439 T1 SI 1173439T1 SI 200030157 T SI200030157 T SI 200030157T SI 200030157 T SI200030157 T SI 200030157T SI 1173439 T1 SI1173439 T1 SI 1173439T1
Authority
SI
Slovenia
Prior art keywords
imidazonaphthyridines
haloalkoxy
compounds
useful
preventing
Prior art date
Application number
SI200030157T
Other languages
English (en)
Slovenian (sl)
Inventor
Gerhard Grundler
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
J�rg SENN-BILFINGER
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1173439T1 publication Critical patent/SI1173439T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Saccharide Compounds (AREA)
SI200030157T 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines SI1173439T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines
EP00918882A EP1173439B1 (de) 1999-04-17 2000-04-14 Haloalkoxy-imidazonaphthyridine

Publications (1)

Publication Number Publication Date
SI1173439T1 true SI1173439T1 (en) 2003-10-31

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030157T SI1173439T1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Country Status (12)

Country Link
US (1) US6503923B1 (de)
EP (1) EP1173439B1 (de)
JP (1) JP2002542248A (de)
AT (1) ATE240956T1 (de)
AU (1) AU3966600A (de)
CA (1) CA2370231A1 (de)
DE (1) DE60002855T2 (de)
DK (1) DK1173439T3 (de)
ES (1) ES2199810T3 (de)
PT (1) PT1173439E (de)
SI (1) SI1173439T1 (de)
WO (1) WO2000063211A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
PL366658A1 (en) 2001-08-02 2005-02-07 Altana Pharma Ag Tricyclic epoxides
BR0211620A (pt) * 2001-08-03 2004-08-24 Altana Pharma Ag Imidazopiridinas substituìdas por alquila para o tratamento de distúrbios gastrointestinais
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
EA008375B1 (ru) 2002-02-15 2007-04-27 Алтана Фарма Аг Трициклические n-ацильные соединения
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA05005117A (es) 2002-11-19 2005-07-01 Altana Pharma Ag Imidazopiridinas 8-sustituidas.
US20060154954A1 (en) * 2003-02-17 2006-07-13 Altana Pharma Ag Combinations and use of selected pharmaceutically active compounds
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
MXPA05012463A (es) * 2003-05-27 2006-01-30 Altana Pharma Ag Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
US7326784B2 (en) 2003-12-19 2008-02-05 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
WO2006037748A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
EE04677B1 (et) * 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim

Also Published As

Publication number Publication date
ATE240956T1 (de) 2003-06-15
CA2370231A1 (en) 2000-10-26
US6503923B1 (en) 2003-01-07
PT1173439E (pt) 2003-10-31
EP1173439A1 (de) 2002-01-23
EP1173439B1 (de) 2003-05-21
ES2199810T3 (es) 2004-03-01
AU3966600A (en) 2000-11-02
DE60002855D1 (de) 2003-06-26
DK1173439T3 (da) 2003-09-08
WO2000063211A1 (en) 2000-10-26
DE60002855T2 (de) 2004-05-06
JP2002542248A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
SI1173439T1 (en) Haloalkoxy imidazonaphthyridines
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
BG106481A (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumour agents
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
NZ516562A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
DE60112974D1 (en) Carbolinderivate
MY121136A (en) Novel heterocyclic sulfonamides.
DE60216233D1 (en) Carbolinderivate
HK1076812A1 (en) Cyanoguanidine prodrugs
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
BG104992A (en) 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n- (6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)- isobutyramide
MY121046A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
TW200508199A (en) Novel compound
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE389655T1 (de) Pyrimidinderivate
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
MXPA03004023A (es) Compuestos quimicos.
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.